Sale by Christopher Ryan Sullivan (Chief Financial Officer)
18,606 shares · @ $24.12 · $448,818
Avalo Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.75
-20% in 7d after detection
Post-detection moves
1h
—
1d
-1.5%
3d
-6.1%
7d
-20%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS